A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.

G. Cook; R.E. Clark; T Morris; M. Robertson; N.P. Lucie; S. Anderson; J. Paul; I.M. Franklin

doi:10.1111/j.1365-2141.2004.05127.x

A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.

G. Cook, R.E. Clark, T Morris, M. Robertson, N.P. Lucie, S. Anderson, J. Paul, I.M. Franklin

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	792-798
Number of pages	7
Journal	British Journal of Haematology
Volume	126(6)
Issue number	6
DOIs	https://doi.org/10.1111/j.1365-2141.2004.05127.x
Publication status	Published - Sept 2004

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/j.1365-2141.2004.05127.x

Cite this

Cook, G., Clark, R. E., Morris, T., Robertson, M., Lucie, N. P., Anderson, S., Paul, J., & Franklin, I. M. (2004). A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma. British Journal of Haematology, 126(6)(6), 792-798. https://doi.org/10.1111/j.1365-2141.2004.05127.x

@article{8980857f860a4afe9e995f5348bde0c9,

title = "A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.",

author = "G. Cook and R.E. Clark and T Morris and M. Robertson and N.P. Lucie and S. Anderson and J. Paul and I.M. Franklin",

year = "2004",

month = sep,

doi = "10.1111/j.1365-2141.2004.05127.x",

language = "English",

volume = "126(6)",

pages = "792--798",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons Inc.",

number = "6",

}

Cook, G, Clark, RE, Morris, T, Robertson, M, Lucie, NP, Anderson, S, Paul, J & Franklin, IM 2004, 'A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.', British Journal of Haematology, vol. 126(6), no. 6, pp. 792-798. https://doi.org/10.1111/j.1365-2141.2004.05127.x

A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma. / Cook, G.; Clark, R.E.; Morris, T et al.
In: British Journal of Haematology, Vol. 126(6), No. 6, 09.2004, p. 792-798.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.

AU - Cook, G.

AU - Clark, R.E.

AU - Morris, T

AU - Robertson, M.

AU - Lucie, N.P.

AU - Anderson, S.

AU - Paul, J.

AU - Franklin, I.M.

PY - 2004/9

Y1 - 2004/9

UR - http://www.scopus.com/inward/record.url?scp=4644305478&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2004.05127.x

DO - 10.1111/j.1365-2141.2004.05127.x

M3 - Article

C2 - 15352982

SN - 0007-1048

VL - 126(6)

SP - 792

EP - 798

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 6

ER -

Cook G, Clark RE, Morris T, Robertson M, Lucie NP, Anderson S et al. A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma. British Journal of Haematology. 2004 Sept;126(6)(6):792-798. doi: 10.1111/j.1365-2141.2004.05127.x

A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myeloma.

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this